The Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) Study Identifies Clinical Prognostic Markers and Establishes the Foundation for Large-Scale Translational Research in Cutaneous Lymphoma

April 2019 in “ Journal of Investigative Dermatology ”

Julia Scarisbrick, Pietro Quaglino, MH Vermeer, Maria Prince, E. Papadavid, Emilia Hodak, S. Whittaker, M. Bagot, Pablo Ortiz, R Stadler, Robert Knobler, Felicity Evison, Eric Hong, Rein Willemze, Y. Kim

cutaneous lymphoma mycosis fungoides Sezary syndrome large cell transformation serum LDH biomarkers

Studysummary This study reported that in mycosis fungoides and Sezary syndrome, there is male predominance and younger age of presentation in early-stage disease, with significant data collection efforts supporting biomarker identification.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer ·

View this study on jidonline.org →

Discuss this study in the Community →

Similar Research

5 / 1000+ results

Characteristics Associated with Significantly Worse Quality of Life in Mycosis Fungoides/Sézary Syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) Study

research Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index ( PROCLIPI ) study

67 citations , May 2019 in “British Journal of Dermatology”

In this study, newly diagnosed women with mycosis fungoides or Sézary syndrome and those with alopecia experienced significantly poorer health-related quality of life.

research C001 Lymphoproliferative disorders

September 1997 in “Journal of The European Academy of Dermatology and Venereology”

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

research 0750 Proteomics and transcriptomics profiling define molecular subtypes of advanced cutaneous T cell lymphoma and prognostic biomarkers

July 2025 in “Journal of Investigative Dermatology”

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

research Scalp Involvement in Primary Cutaneous Lymphomas—An Update on Clinical Presentation, Diagnostics, and Management

May 2025 in “Cancers”

This review analyzed literature on primary cutaneous lymphomas involving the scalp, finding that scalp involvement in these cases often leads to non-scarring focal alopecia and may indicate more aggressive disease.

research CUTANEOUS T-CELL LYMPHOMA

11 citations , October 2001 in “Dermatologic Clinics”

In this study, subcutaneous recombinant human IL-12 showed a 43% partial response rate in early-stage mycosis fungoides patients refractory to previous treatments, with generally mild to moderate adverse events reported.